Judge Lamberth’s court injunction on federal funding of embryonic stem cell research was temporarily lifted September 9, but much remains in question. In today’s edition of Nature (September 23rd), a legal panel examines the case. Panelist Patrick Taylor, former Chief Counsel for Research Affairs at Children’s, weighs in on the ambiguities of the Dickey-Wicker amendment, what kind of legislative action is needed, and the prospects for NIH funding of research on the embryonic stem cell lines created under Obama, the so-called Bush Lines, and new lines waiting to be created.
Related Posts :
- Could a simple injection fix spina bifida before birth?
- Creating custom brains from the ground up
- Can we teach heart cells to grow up?
- Why blood stem cells are in our bones: Evolutionary observation may inform better bone marrow transplants
- Poised pluripotency: A glimpse of the early embryo just as it’s implanting